<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04361188</url>
  </required_header>
  <id_info>
    <org_study_id>FS20191119007</org_study_id>
    <nct_id>NCT04361188</nct_id>
  </id_info>
  <brief_title>UPDRS-III Comparisons of DBS for PD Between Patients Receiving MAC and AAA Anesthesia</brief_title>
  <official_title>UPDRS-III Comparisons of Deep Brain Stimulation for Parkinson's Disease Between Patients Receiving MAC and AAA Anesthesia: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shenzhen Second People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shenzhen Second People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compares the patients' scores of UPDRS-III before and six-month after receiving deep brain
      stimulation for Parkinson's disease under MAC or AAA anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Compares the patients' scores of UPDRS-III before and six-month after receiving deep brain
      stimulation for Parkinson's disease under MAC or AAA anesthesia. Besides, the research also
      compares the adverse events, LED, dosage of anesthetic drugs, wake-up time, surgical time,
      Hoehn&amp;Yahr, PQD-39, MMSE, MoCA, HAMA, HAMD and patients' satisfaction between the two groups
      mentioned above.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Scores' change of Unified Parkinson's Rating Scale (part III/motor part)</measure>
    <time_frame>Before and six-month after DBS.</time_frame>
    <description>Compares the scores' change of Unified Parkinson's Rating Scale (part III/motor part) between the two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Levodopa Equivalent Dose</measure>
    <time_frame>Before and six-month after DBS.</time_frame>
    <description>Compares the change of Levodopa equivalent dose between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of Adverse Events</measure>
    <time_frame>Intra-operative.</time_frame>
    <description>Compares the rates of adverse events between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosage of Anesthetic Drugs</measure>
    <time_frame>Within surgery.</time_frame>
    <description>Compares the dosage of anesthetic between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wake-up Time</measure>
    <time_frame>Within surgery.</time_frame>
    <description>Compares the wake-up time between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Time</measure>
    <time_frame>Within surgery.</time_frame>
    <description>Compares the surgical time between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hoehn&amp;Yahr</measure>
    <time_frame>Before surgery.</time_frame>
    <description>Compares the Hoehn&amp;Yahr classification between the two groups' patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' Satisfaction(Visual Analogue Scale)</measure>
    <time_frame>24 hours after surgery.</time_frame>
    <description>Compares the scores of patients' satisfaction between the two groups' patients by Using a visual analogue scale. The minimum value is 0 and maximum value is 10. Higher value means greater satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores' change of 39-item Parkinson's Disease Questionnaire</measure>
    <time_frame>Before and six-month after DBS.</time_frame>
    <description>Compares the scores' change of 39-item Parkinson's Disease Questionnaire between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores' change of Mini-mental State Examination</measure>
    <time_frame>Before and six-month after DBS.</time_frame>
    <description>Compares the scores' change of Mini-mental State Examination between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores' change of Montreal Cognitive Assessment</measure>
    <time_frame>Before and six-month after DBS.</time_frame>
    <description>Compares the scores' change of Montreal Cognitive Assessment between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores' change of Hamilton Anxiety Scale</measure>
    <time_frame>Before and six-month after DBS.</time_frame>
    <description>Compares the scores' change of Hamilton Anxiety Scale between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores' change of Hamilton Depression Scale</measure>
    <time_frame>Before and six-month after DBS.</time_frame>
    <description>Compares the scores' change of Hamilton Depression Scale between the two groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>MAC anesthesia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Parkinson's disease patients receiving deep brain stimulation under MAC anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AAA anesthesia group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Parkinson's disease patients receiving deep brain stimulation under AAA anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MAC anesthesia</intervention_name>
    <description>Patients receives DBS under monitored anesthesia care.</description>
    <arm_group_label>MAC anesthesia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AAA anesthesia</intervention_name>
    <description>Patients receives DBS under asleep-awake-asleep anesthesia.</description>
    <arm_group_label>AAA anesthesia group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater than 18 years old

          -  Diagnosis of primary Parkinson's disease

          -  Parkinson's disease-related symptoms remain difficult to control with appropriate
             anti-parkinsonian medications.

        Exclusion Criteria:

          -  Refusal to Participate in the research

          -  Patients with severe comorbidities such as severe sleep apnea syndrome and metal
             disorder

          -  Previous functional neurosurgery: DBS, thalamic incision, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liu Zhiheng, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Anesthesia department of Shenzhen Second People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liu Zhiheng, Doctor</last_name>
    <phone>15818585570</phone>
    <email>15818585570@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zheng Sihao, Bachelor</last_name>
    <phone>18816791174</phone>
    <email>zhengc2020@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shenzhen Second People's Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518035</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liu Zhiheng, Doctor</last_name>
      <phone>15818585570</phone>
      <email>15818585570@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Ho AL, Pendharkar AV, Brewster R, Martinez DL, Jaffe RA, Xu LW, Miller KJ, Halpern CH. Frameless Robot-Assisted Deep Brain Stimulation Surgery: An Initial Experience. Oper Neurosurg (Hagerstown). 2019 Oct 1;17(4):424-431. doi: 10.1093/ons/opy395.</citation>
    <PMID>30629245</PMID>
  </results_reference>
  <results_reference>
    <citation>Kulikov A, Lubnin A. Anesthesia for awake craniotomy. Curr Opin Anaesthesiol. 2018 Oct;31(5):506-510. doi: 10.1097/ACO.0000000000000625. Review.</citation>
    <PMID>29994938</PMID>
  </results_reference>
  <results_reference>
    <citation>Krauss P, Marahori NA, Oertel MF, Barth F, Stieglitz LH. Better Hemodynamics and Less Antihypertensive Medication: Comparison of Scalp Block and Local Infiltration Anesthesia for Skull-Pin Placement in Awake Deep Brain Stimulation Surgery. World Neurosurg. 2018 Dec;120:e991-e999. doi: 10.1016/j.wneu.2018.08.210. Epub 2018 Sep 7.</citation>
    <PMID>30196173</PMID>
  </results_reference>
  <results_reference>
    <citation>Kochanski RB, Sani S. Awake versus Asleep Deep Brain Stimulation Surgery: Technical Considerations and Critical Review of the Literature. Brain Sci. 2018 Jan 19;8(1). pii: E17. doi: 10.3390/brainsci8010017. Review.</citation>
    <PMID>29351243</PMID>
  </results_reference>
  <results_reference>
    <citation>Ho AL, Ali R, Connolly ID, Henderson JM, Dhall R, Stein SC, Halpern CH. Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis. J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):687-691. doi: 10.1136/jnnp-2016-314500. Epub 2017 Mar 1.</citation>
    <PMID>28250028</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen T, Mirzadeh Z, Chapple KM, Lambert M, Shill HA, Moguel-Cobos G, Tr√∂ster AI, Dhall R, Ponce FA. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2018 Mar 16;130(1):109-120. doi: 10.3171/2017.8.JNS17883.</citation>
    <PMID>29547091</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen T, Mirzadeh Z, Chapple KM, Lambert M, Evidente VGH, Moguel-Cobos G, Oravivattanakul S, Mahant P, Ponce FA. Intraoperative test stimulation versus stereotactic accuracy as a surgical end point: a comparison of essential tremor outcomes after ventral intermediate nucleus deep brain stimulation. J Neurosurg. 2018 Aug;129(2):290-298. doi: 10.3171/2017.3.JNS162487. Epub 2017 Oct 13.</citation>
    <PMID>29027853</PMID>
  </results_reference>
  <results_reference>
    <citation>Sheshadri V, Rowland NC, Mehta J, Englesakis M, Manninen P, Venkatraghavan L. Comparison of General and Local Anesthesia for Deep Brain Stimulator Insertion: A Systematic Review. Can J Neurol Sci. 2017 Nov;44(6):697-704. doi: 10.1017/cjn.2017.224. Epub 2017 Sep 18.</citation>
    <PMID>28920562</PMID>
  </results_reference>
  <results_reference>
    <citation>Grant R, Gruenbaum SE, Gerrard J. Anaesthesia for deep brain stimulation: a review. Curr Opin Anaesthesiol. 2015 Oct;28(5):505-10. doi: 10.1097/ACO.0000000000000230. Review.</citation>
    <PMID>26308514</PMID>
  </results_reference>
  <results_reference>
    <citation>Erickson KM, Cole DJ. Anesthetic considerations for awake craniotomy for epilepsy and functional neurosurgery. Anesthesiol Clin. 2012 Jun;30(2):241-68. doi: 10.1016/j.anclin.2012.05.002. Epub 2012 Jul 3. Review.</citation>
    <PMID>22901609</PMID>
  </results_reference>
  <results_reference>
    <citation>Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, Pahwa R, Henderson JM, Hariz MI, Bakay RA, Rezai A, Marks WJ Jr, Moro E, Vitek JL, Weaver FM, Gross RE, DeLong MR. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011 Feb;68(2):165. doi: 10.1001/archneurol.2010.260. Epub 2010 Oct 11. Review.</citation>
    <PMID>20937936</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 21, 2020</study_first_submitted>
  <study_first_submitted_qc>April 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shenzhen Second People's Hospital</investigator_affiliation>
    <investigator_full_name>ZhiHeng Liu</investigator_full_name>
    <investigator_title>Head of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>UPDRS-III</keyword>
  <keyword>Deep Brain Stimulation</keyword>
  <keyword>MAC</keyword>
  <keyword>AAA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

